Published in AIDS on July 01, 1987
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74
HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health (2005) 2.62
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction (2005) 1.32
Improving survival among HIV-infected injection drug users: how should we define success? Clin Infect Dis (2007) 1.02
Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (2000) 1.00
Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (2006) 0.99
Implications of the revised surveillance definition: AIDS among New York City drug users. Am J Public Health (1992) 0.92
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. BMJ (1990) 0.91
Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis. West J Med (1990) 0.88
Short-term declines in CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting drug users. J Natl Med Assoc (1993) 0.87
Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users. J Natl Med Assoc (1996) 0.84
Slow progression to AIDS in intravenous drug users infected with HIV in Norway. J Epidemiol Community Health (1994) 0.77
Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users. Clin Diagn Lab Immunol (1996) 0.76
Accounting for dropout reason in longitudinal studies with nonignorable dropout. Stat Methods Med Res (2015) 0.75
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell (1993) 13.54
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet (1999) 8.91
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol (2007) 5.12
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98
Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88
A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology (1991) 4.83
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA (1997) 4.79
Structural interventions: concepts, challenges and opportunities for research. J Urban Health (2006) 4.70
Risk factors for Kaposi's sarcoma in homosexual men. Lancet (1982) 4.70
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med (1995) 3.83
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med (1985) 3.63
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA (1994) 3.41
Renal function during antihypertensive treatment. Lancet (1995) 3.33
Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med (1982) 3.29
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS (1987) 3.24
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health (1995) 3.24
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
International epidemiology of HIV and AIDS among injecting drug users. AIDS (1992) 3.19
Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav (1988) 3.14
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med (1994) 3.05
AIDS health education for intravenous drug users. Health Educ Q (1986) 2.92
HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis (1988) 2.91
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74
Interferon-associated retinopathy. Arch Ophthalmol (1993) 2.73
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma. Am J Med (1982) 2.71
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med (1992) 2.64
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
The AIDS epidemic among blacks and Hispanics. Milbank Q (1987) 2.54
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS (1998) 2.53
Somatization symptoms in pediatric abdominal pain patients: relation to chronicity of abdominal pain and parent somatization. J Abnorm Child Psychol (1991) 2.50
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Sexual transmission of enteric protozoa and helminths in a venereal-disease-clinic population. N Engl J Med (1981) 2.47
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44
High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.38
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet (1999) 2.36
Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med (1983) 2.36
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health (1998) 2.28
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr (2000) 2.22
Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. J Abnorm Psychol (1993) 2.21
Guidelines for the clinical use of red cell transfusions. Br J Haematol (2001) 2.21
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science (1988) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG (2013) 2.16
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Venereal transmission of enteric pathogens in male homosexuals. Two case reports. JAMA (1977) 2.13
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health (2000) 2.09
Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. J Clin Invest (1984) 2.07
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Self-destructing (non-reusable) syringes. Lancet (1991) 2.04
Methods for managing the increased workload in anticoagulant clinics. BMJ (1996) 2.03